<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01851044</url>
  </required_header>
  <id_info>
    <org_study_id>R11031</org_study_id>
    <nct_id>NCT01851044</nct_id>
  </id_info>
  <brief_title>The Effect of Platelet Rich Plasma on Lateral Epicondylitis</brief_title>
  <official_title>The Treatment of Lateral Epicondylitis: the Effect of Platelet Rich Plasma on Healing -- A Randomized Controlled Double-Blinded Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hatanpää City Hospital, Tampere, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effects of platelet rich plasma, whole blood and&#xD;
      saline vehicle on the natural course of lateral epicondylitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lateral epicondylitis, also known as &quot;tennis elbow&quot;, is the most common work-related disease&#xD;
      of the upper extremity. Usually it has favorable natural healing-tendency, but sometimes it&#xD;
      is responsible for long-lasting disability. The pathogenesis of this disease has remained&#xD;
      unclear, however it has been speculated that the role of inflammation is smaller than&#xD;
      previously believed. Instead, anatomical and vascular factors may play a much greater role.&#xD;
      The evidence for the operative treatment is lacking, and the conservative treatment is&#xD;
      therefore preferred. The conservative treatment used to rely largely on corticosteroid&#xD;
      injections to the extensor muscle insertions. However, it has been shown that&#xD;
      corticosteroids, in fact, tend to increase the subjective pain in the long run. Several&#xD;
      studies -- most of them unfortunately underpowered -- have been carried out to find an&#xD;
      efficient conservative treatment to this disease, but none of them has turned out to be&#xD;
      significantly better than others. During the last couple of years, platelet rich plasma (PRP)&#xD;
      has been used as a treatment in several musculoskeletal diseases (e.g. fracture healing,&#xD;
      cartilage regeneration, wound healing). PRP is a substance centrifuged from patient own&#xD;
      blood. There are a couple of studies regarding the use of PRP in lateral epicondylitis. The&#xD;
      results are mostly positive; however it has not been thoroughly shown that it would be more&#xD;
      effective than patient's whole blood. The hypothesis of this study is that PRP is more&#xD;
      effective in the treatment of lateral epicondylitis than whole blood or saline vehicle&#xD;
      injection. The primary outcome measures are pain (VAS) and the Disabilities of the Arm,&#xD;
      Shoulder and Hand -score (DASH).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain (Visual Analog Scale)</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disabilities of the Arm, Shoulder and Hand -score</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Grip strength (Jamar)</measure>
    <time_frame>52 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Need for non-steroidal anti-inflammatory drugs (NSAID)</measure>
    <time_frame>52 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The duration of the potential sick leave due to lateral epicondylitis</measure>
    <time_frame>52 weeks</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Lateral Epicondylitis</condition>
  <condition>Elbow Pain</condition>
  <arm_group>
    <arm_group_label>Vehicle (Saline)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 ml of saline is injected to the proximal insertion of extensor carpi radialis brevis (ECRB) muscle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole Blood</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 ml of patient own venous blood is injected to the proximal insertion of ECRB.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platelet Rich Plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>9 ml of patient own venous blood is centrifuged using The Arthrex ACP® Double Syringe System and 2 ml of platelet rich plasma is injected to the proximal insertion of ECRB.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet Rich Plasma</intervention_name>
    <arm_group_label>Vehicle (Saline)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Whole Blood Injection</intervention_name>
    <arm_group_label>Whole Blood</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline Injection</intervention_name>
    <arm_group_label>Platelet Rich Plasma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The duration of symptoms over 3 months&#xD;
&#xD;
          -  Primary conservative treatment (physiotherapy, NSAID, ...) has been tried&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant systemic diseases&#xD;
&#xD;
          -  Any surgical operation of the particular elbow&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hatanpää City Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33101</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>May 5, 2013</study_first_submitted>
  <study_first_submitted_qc>May 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2013</study_first_posted>
  <last_update_submitted>October 10, 2018</last_update_submitted>
  <last_update_submitted_qc>October 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University</investigator_affiliation>
    <investigator_full_name>Olli Leppänen</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Platelet Rich Plasma</keyword>
  <keyword>Whole Blood Injection</keyword>
  <keyword>Lateral Epicondylitis</keyword>
  <keyword>Tennis Elbow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

